ArticlePloS one2026
Longitudinal evidence of technology-enhanced, individualized neuromotor rehabilitation on autonomy, cognition, quality of life, and psychological well-being: Pilot multi-sample study.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05399043 (Perception of High Technology in Rehabilitation), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Perception of High Technology in Rehabilitation: a Prospective Real-life Study on Usability, Effectiveness, and Health-related Quality of Life (PHTinRehab Study)
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOver the last decades, neuromotor rehabilitation programs have integrated multidisciplinary approaches with the implementation of emerging technology (e.g., robotics and virtual reality - VR), to effectively target recovery complexity. While this strategy supported patient's physical improvement, little evidence has been reported regarding the widespread effects on non-motor rehabilitation outcomes.
methodsA prospective, two-arm, non-randomized study design was adopted to provide pilot feasibility evidence on the multi-domain impact of personalized technology-enhanced neuromotor rehabilitation from convenience sub-samples of patients with stroke, Parkinson's Disease (PD), and osteoarthritis (OA). Technological intervention consisted of the integrated use of robot-assisted and/or VR-based exercises, individualized based on patient's diagnosis and rehabilitation goals. Study outcomes included patient's functional status (autonomy in ADLs, risk of falls), cognition (attention and executive functions, memory, verbal fluency), physical and mental health-related quality of life (HRQoL), and psychological status (anxiety and depression symptoms, and well-being) and were compared to patients participating in standard training only. Rehabilitation experience and technology psychosocial impact were also evaluated. Intra- and intergroup comparisons along with general linear models were statistically tested within each sub-sample considered independently over three timepoints (baseline, post-intervention, 6-month follow-up).
resultsAt post-intervention, significant multi-domain intra-group improvements were observed within each sub-sample. Between-group differences were found on ADLs autonomy (stroke and PD; p < .05), executive functions (stroke; p < .01), anxiety and depression (OA and PD, respectively; p < .05), and well-being (stroke and OA; p < .05). Interaction effects (time x group) were significant only on well-being variables in stroke (p = .01) and OA (p = .02), evidencing wider short-term effects of technology-enhanced programs compared to standard training. At 6-month, significant time effects indicating sustained improvements over the three timepoints were estimated on HRQoL within each sub-sample (p < .05) and, additionally, on anxiety and depression in stroke (p = .02) and OA (p < .001). Interaction effects emerged only on physical HRQoL in OA (p = .02), along with significant between-group differences on HRQoL and anxiety and depression in OA (p < .05) and PD (p = .01), respectively.
conclusionFurther full-scale trials are warranted to confirm the longitudinal trends observed in this pilot study and to further investigate the potential multi-domain benefits of multidisciplinary and technology-integrated recovery approaches across different clinical populations.
trial registrationClinicalTrials.gov ID: NCT05399043.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.